-
1
-
-
13444269601
-
Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study
-
Alsaadi TM, Shatzel A, Marquez AV, et al. 2005. Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study. Seizure, 14:139-42.
-
(2005)
Seizure
, vol.14
, pp. 139-142
-
-
Alsaadi, T.M.1
Shatzel, A.2
Marquez, A.V.3
-
2
-
-
33847625508
-
Levetiracetam intravenous infusion as as alternative to oral dosing in patients with partial-onset seizures
-
Baulac M, Brodie MJ, Christian EE, et al. 2007. Levetiracetam intravenous infusion as as alternative to oral dosing in patients with partial-onset seizures. Epilepsia, 48:589-92.
-
(2007)
Epilepsia
, vol.48
, pp. 589-592
-
-
Baulac, M.1
Brodie, M.J.2
Christian, E.E.3
-
3
-
-
0033775210
-
Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy
-
Ben-Menachem E, Falter U. 2000. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia, 41:1276-83.
-
(2000)
Epilepsia
, vol.41
, pp. 1276-1283
-
-
Ben-Menachem, E.1
Falter, U.2
-
4
-
-
33846850154
-
Comparison of levetiracetam and controlled release carbamazepine in newly diagnosed epilepsy
-
Brodie MJ, Perucca E., Ryvilin P., et al. 2007. Comparison of levetiracetam and controlled release carbamazepine in newly diagnosed epilepsy. Neurology, 68:402-8.
-
(2007)
Neurology
, vol.68
, pp. 402-408
-
-
Brodie, M.J.1
Perucca, E.2
Ryvilin, P.3
-
5
-
-
0033663648
-
Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique
-
Browne TR, Szabo GK, Leppik IE, et al. 2000. Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique. J Clin Pharmacol, 40:590-5.
-
(2000)
J Clin Pharmacol
, vol.40
, pp. 590-595
-
-
Browne, T.R.1
Szabo, G.K.2
Leppik, I.E.3
-
6
-
-
0033854805
-
Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial
-
Cereghino JJ, Biton V, Abou-Khalil B, et al. 2000. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology, 55:236-42.
-
(2000)
Neurology
, vol.55
, pp. 236-242
-
-
Cereghino, J.J.1
Biton, V.2
Abou-Khalil, B.3
-
7
-
-
0033756611
-
Levetiracetam: A review of its adjunctive use in the management of partial onset seizures
-
Dooley M, Plosker GL. 2000. Levetiracetam: a review of its adjunctive use in the management of partial onset seizures. Drugs, 60:871-93.
-
(2000)
Drugs
, vol.60
, pp. 871-893
-
-
Dooley, M.1
Plosker, G.L.2
-
8
-
-
13244272154
-
Rapid onset of action of levetiracetam in refractory epilepsy patients
-
French J, Arrigo C. 2005. Rapid onset of action of levetiracetam in refractory epilepsy patients. Epilepsia, 46:324-6.
-
(2005)
Epilepsia
, vol.46
, pp. 324-326
-
-
French, J.1
Arrigo, C.2
-
9
-
-
0034768383
-
A systematic review of the safety profile of levetiracetam: A new antiepileptic drug
-
French J, Edrich P, Cramer JA. 2001. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res, 47:77-90.
-
(2001)
Epilepsy Res
, vol.47
, pp. 77-90
-
-
French, J.1
Edrich, P.2
Cramer, J.A.3
-
10
-
-
11144356543
-
Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy
-
French JA, Kanner AM, Bautista J, et al. 2004a. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy. Neurology, 62:1252-60.
-
(2004)
Neurology
, vol.62
, pp. 1252-1260
-
-
French, J.A.1
Kanner, A.M.2
Bautista, J.3
-
11
-
-
11144353969
-
Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy
-
French JA, Kanner AM, Bautista J, et al. 2004b. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Neurology, 62:1261-73.
-
(2004)
Neurology
, vol.62
, pp. 1261-1273
-
-
French, J.A.1
Kanner, A.M.2
Bautista, J.3
-
12
-
-
19444366567
-
Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: A pooled analysis of data from randomized clinical trials
-
Gidal BE, Baltès E, Otoul C, et al. 2005. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials. Epilepsy Res, 64:1-11.
-
(2005)
Epilepsy Res
, vol.64
, pp. 1-11
-
-
Gidal, B.E.1
Baltès, E.2
Otoul, C.3
-
13
-
-
33745665605
-
Double-blind, randomized, placebo-controlled trial of adjunctive levetiracetain in pediatric partial seizures
-
Glauser TA, Ayala R, Elterman RD, et al. 2006. Double-blind, randomized, placebo-controlled trial of adjunctive levetiracetain in pediatric partial seizures. Neurology, 66:1654-60.
-
(2006)
Neurology
, vol.66
, pp. 1654-1660
-
-
Glauser, T.A.1
Ayala, R.2
Elterman, R.D.3
-
14
-
-
0036091188
-
Efficacy and safety of levetiracetam in children with partial seizures: An open-label trial
-
Glauser TA, Pellock JM, Bebin EM, et al. 2002. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial. Epilepsia, 43:518-24.
-
(2002)
Epilepsia
, vol.43
, pp. 518-524
-
-
Glauser, T.A.1
Pellock, J.M.2
Bebin, E.M.3
-
15
-
-
0028823233
-
Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy
-
Gower AJ, Hirsch E, Boehrer A, et al. 1995. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res, 22:207-13.
-
(1995)
Epilepsy Res
, vol.22
, pp. 207-213
-
-
Gower, A.J.1
Hirsch, E.2
Boehrer, A.3
-
16
-
-
0026471112
-
UCB L059, a novel anticonvulsant drug: Pharmacological profile in animals
-
Gower AJ, Noyer M, Verloes R, et al. 1992. UCB L059, a novel anticonvulsant drug: pharmacological profile in animals. Eur J Pharmacol, 222:193-203.
-
(1992)
Eur J Pharmacol
, vol.222
, pp. 193-203
-
-
Gower, A.J.1
Noyer, M.2
Verloes, R.3
-
17
-
-
0034878396
-
Safety profile of levetiracetam
-
Harden C. 2001. Safety profile of levetiracetam. Epilepsia, 42(Suppl 4):36-9.
-
(2001)
Epilepsia
, vol.42
, Issue.SUPPL. 4
, pp. 36-39
-
-
Harden, C.1
-
18
-
-
0035169113
-
Levetiracetam: A novel antiepileptic drug
-
Hovinga CA. 2001. Levetiracetam: a novel antiepileptic drug. Pharmacotherapy, 21:1375-88.
-
(2001)
Pharmacotherapy
, vol.21
, pp. 1375-1388
-
-
Hovinga, C.A.1
-
19
-
-
0030297525
-
Photosensitive epilepsy: A model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam
-
Kasteleijn-Nolst Trenité DGA, Marescaux C, Stodieck S, et al. 1996. Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam. Epilepsy Res, 25:225-30.
-
(1996)
Epilepsy Res
, vol.25
, pp. 225-230
-
-
Kasteleijn-Nolst Trenité, D.G.A.1
Marescaux, C.2
Stodieck, S.3
-
20
-
-
41549165909
-
Summary of product characteristics. Brussels, Belgium: UCB SA
-
250 mg, 500 mg, 1000 mg, June
-
Keppre™ (250 mg, 500 mg, 1000 mg). 2000b. Summary of product characteristics. Brussels, Belgium: UCB SA. June 2000.
-
(2000)
-
-
Keppre™1
-
21
-
-
41549162651
-
-
Keppra™ levetiracetam 250, 500, 750 mg tablets. 2000a. Prescribing information. Brussels, Belgium: UCB Pharma.
-
Keppra™ levetiracetam 250, 500, 750 mg tablets. 2000a. Prescribing information. Brussels, Belgium: UCB Pharma.
-
-
-
-
22
-
-
0032563178
-
Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
-
Klitgaard R, Matagne A, Gobert J, et al. 1998. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol, 353:191-206.
-
(1998)
Eur J Pharmacol
, vol.353
, pp. 191-206
-
-
Klitgaard, R.1
Matagne, A.2
Gobert, J.3
-
23
-
-
0034864144
-
Levetiracetam: The preclinical profile of a new class of antiepileptic drugs?
-
Klitgaard H. 2001, Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia, 42(Suppl 4):13-18.
-
(2001)
Epilepsia
, vol.42
, Issue.SUPPL. 4
, pp. 13-18
-
-
Klitgaard, H.1
-
24
-
-
0035673064
-
Levetiracetam psychosis in children with epilepsy
-
Kossoff EH, Bergey GK, Freeman JM, et al. 2001. Levetiracetam psychosis in children with epilepsy. Epilepsia, 42:1611-3.
-
(2001)
Epilepsia
, vol.42
, pp. 1611-1613
-
-
Kossoff, E.H.1
Bergey, G.K.2
Freeman, J.M.3
-
25
-
-
0035954353
-
Long-term continuation of levetiracetam in patients with refractory epilepsy
-
Krakow D, Walker W, Otoul C, et al. 2001. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology, 56:1772-4.
-
(2001)
Neurology
, vol.56
, pp. 1772-1774
-
-
Krakow, D.1
Walker, W.2
Otoul, C.3
-
26
-
-
33645022604
-
Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study
-
Labate A, Colosimo E, Gambardella A, et al. 2006. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study. Seizure, 15:214-8.
-
(2006)
Seizure
, vol.15
, pp. 214-218
-
-
Labate, A.1
Colosimo, E.2
Gambardella, A.3
-
27
-
-
0347994963
-
Levetiracetam and partial seizure subtypes: Pooled data from three randomized, placebo-controlled trials
-
Leppik IE, Biton V, Sander JW, et al. 2003. Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials. Epilepsia, 44:1585-7.
-
(2003)
Epilepsia
, vol.44
, pp. 1585-1587
-
-
Leppik, I.E.1
Biton, V.2
Sander, J.W.3
-
28
-
-
0034900762
-
Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers
-
Levy RH, Ragueneau-Majlessi I, Baltes E. 2001. Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers. Epilepsy Res, 46:93-9.
-
(2001)
Epilepsy Res
, vol.46
, pp. 93-99
-
-
Levy, R.H.1
Ragueneau-Majlessi, I.2
Baltes, E.3
-
29
-
-
0031908063
-
Antiepileptogenic effects of the novel anticonvulsant levetiracetam. (ucb L059) in the kindling model of temporal lobe epilepsy
-
Löscher W, Hönack D, Rundfeldt C. 1998. Antiepileptogenic effects of the novel anticonvulsant levetiracetam. (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther, 284:474-9.
-
(1998)
J Pharmacol Exp Ther
, vol.284
, pp. 474-479
-
-
Löscher, W.1
Hönack, D.2
Rundfeldt, C.3
-
30
-
-
0027410987
-
Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalised epilepsy in mice and rats
-
Löscher W, Hönack D. 1993. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalised epilepsy in mice and rats. Eur J Pharmacol, 232:147-58.
-
(1993)
Eur J Pharmacol
, vol.232
, pp. 147-158
-
-
Löscher, W.1
Hönack, D.2
-
31
-
-
34247096547
-
Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: An isobolographic analysis in the mouse maximal electroshock model
-
Luszczki JJ, Andres-Mach MM, Ratnaraj N, et al. 2007. Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model. Epilepsia, 48:806-15.
-
(2007)
Epilepsia
, vol.48
, pp. 806-815
-
-
Luszczki, J.J.1
Andres-Mach, M.M.2
Ratnaraj, N.3
-
32
-
-
0002260079
-
Effect of levetiracetam on voltage-gated, potassium channels: A novel anti-epileptic mechanism?
-
Madeja M, Margineanou D, Klitgaard H. 2001. Effect of levetiracetam on voltage-gated, potassium channels: a novel anti-epileptic mechanism? Epilepsia, 42(suppl 2):19.
-
(2001)
Epilepsia
, vol.42
, Issue.SUPPL. 2
, pp. 19
-
-
Madeja, M.1
Margineanou, D.2
Klitgaard, H.3
-
33
-
-
0042836602
-
Psychiatric adverse events during levetiracetam therapy
-
Mula M, Trimble MR, Yuen A, et al. 2003. Psychiatric adverse events during levetiracetam therapy. Neurology, 61:704-6.
-
(2003)
Neurology
, vol.61
, pp. 704-706
-
-
Mula, M.1
Trimble, M.R.2
Yuen, A.3
-
35
-
-
0032963256
-
In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent
-
Nicolas JM, Collart P, Germ B, et al. 1999. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent. Drug Metab Dispos, 27:250-4.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 250-254
-
-
Nicolas, J.M.1
Collart, P.2
Germ, B.3
-
37
-
-
0028825031
-
The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes
-
Noyer M, Gillard M, Matagne A, et al. 1995. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol, 286:137-46.
-
(1995)
Eur J Pharmacol
, vol.286
, pp. 137-146
-
-
Noyer, M.1
Gillard, M.2
Matagne, A.3
-
38
-
-
0035675738
-
Pharmacokinetic study of levetiracetam in children
-
Pellock JM, Glauser TA, Bebin EM, et al. 2001. Pharmacokinetic study of levetiracetam in children. Epilepsia, 42:1574-9.
-
(2001)
Epilepsia
, vol.42
, pp. 1574-1579
-
-
Pellock, J.M.1
Glauser, T.A.2
Bebin, E.M.3
-
39
-
-
0034864245
-
Pharmacokinetics of levetiracetain
-
Radtke RA. 2001. Pharmacokinetics of levetiracetain. Epilepsia, 42(Suppl 4):24-7.
-
(2001)
Epilepsia
, vol.42
, Issue.SUPPL. 4
, pp. 24-27
-
-
Radtke, R.A.1
-
40
-
-
33746115639
-
Levetiracetam intravenous infusion: A randomized, placebo-controlled safety and pharmacokinetic study
-
Ramael S, Daoust A, Otoul C, et al. 2006b. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia. 47:1128-35.
-
(2006)
Epilepsia
, vol.47
, pp. 1128-1135
-
-
Ramael, S.1
Daoust, A.2
Otoul, C.3
-
41
-
-
33745974941
-
Single dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects
-
Ramael S, De Smedt F, Toublanc N, et al. 2006. Single dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin Ther, 28:734-44.
-
(2006)
Clin Ther
, vol.28
, pp. 734-744
-
-
Ramael, S.1
De Smedt, F.2
Toublanc, N.3
-
42
-
-
33745974941
-
Single-dose bioavalability of levetiravetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects
-
Ramael S, De Smedt F, Toublanc N, et al. 2006a. Single-dose bioavalability of levetiravetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clinical Therapeutics, 28:734-44.
-
(2006)
Clinical Therapeutics
, vol.28
, pp. 734-744
-
-
Ramael, S.1
De Smedt, F.2
Toublanc, N.3
-
43
-
-
0002349243
-
Levetiracetam: Novel modulation of ionotropic inhibitory receptors
-
Rigo J-K Nguyen L, Belachew S, et al. 2000. Levetiracetam: novel modulation of ionotropic inhibitory receptors. Epilepsia, 41(Suppl 7):35.
-
(2000)
Epilepsia
, vol.41
, Issue.SUPPL. 7
, pp. 35
-
-
Rigo, J.-K.1
Nguyen, L.2
Belachew, S.3
-
44
-
-
0033811027
-
Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures
-
Shorvon SD, Lowenthal A, Janz D, et al. 2000. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia, 41:1179-86.
-
(2000)
Epilepsia
, vol.41
, pp. 1179-1186
-
-
Shorvon, S.D.1
Lowenthal, A.2
Janz, D.3
-
46
-
-
0035655764
-
Pyrrolidone derivatives
-
Shorvon SD. 2001. Pyrrolidone derivatives. Lancet, 200:1885-92.
-
(2001)
Lancet
, vol.200
, pp. 1885-1892
-
-
Shorvon, S.D.1
-
47
-
-
33645019934
-
Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: A multicenter, randomized, double-blind, placebo-controlled study
-
Tsai JJ, Yen DJ, Hsih MS, et al. 2006. Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study. Epilepsia, 47:72-81.
-
(2006)
Epilepsia
, vol.47
, pp. 72-81
-
-
Tsai, J.J.1
Yen, D.J.2
Hsih, M.S.3
-
48
-
-
0034883899
-
Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents
-
Zona C, Niespodziany I, Marchetti C, et al. 2001. Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents. Seizure, 10:279-86.
-
(2001)
Seizure
, vol.10
, pp. 279-286
-
-
Zona, C.1
Niespodziany, I.2
Marchetti, C.3
|